ly to publishing ezine information. One list is published on this website -
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
"_new" href="http://www.bellaonline.com/articles/art12836.asp">http://www.bellaonline
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
com/articles/art12836.asp
2) Offer subscribers something free in return for thei
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
subscription to your ezine. This could be a free report, a free advertisement in a f
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ture issue of your publication, a free ebook, etc...
3) Submit the details of your n
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
w ezine to as all related Announcement Lists. Depending upon your content, you may fi
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
icles/art12838.asp">http://www.bellaonline.com/articles/art12838.asp
4) Talk abo
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
t your latest endeavor in online forums related to your ezine topic. You can find var
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ous lists of forums by searching Google, Yahoo or Dogpile.
5) Reward subscribers for
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
referring new subscribers. Again this can be in the form of a free advertisement for
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
ach person they recommend to your ezine (who actually becomes a subscriber.)
Remembe
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
that you definitely have competition for readership. There are probably plenty of ne
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
sletters online, which are similar to yours. You have to make it stand out from the c
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
owd. Make it different, more appealing, more informative, etc...
Best of luck to you
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products